Dr. Elizabeth Brem, MD
Claim this profileUC Irvine Health/Chao Family Comprehensive Cancer Center
Area of expertise
Lymphoma
Elizabeth Brem, MD has run 4 trials for Lymphoma. Some of their research focus areas include:
Large B-Cell Lymphoma
Elizabeth Brem, MD has run 3 trials for Large B-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
UC Irvine Health/Chao Family Comprehensive Cancer Center
UCI Health - Chao Family Comprehensive Cancer Center And Ambulatory Care
Clinical Trials Elizabeth Brem, MD is currently running
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting
2 awards
Phase 3
13 criteria
Post-CAR T-cell Therapy Drug Combo
for Non-Hodgkin's Lymphoma
This trial is testing two treatments, mosunetuzumab and polatuzumab vedotin, for patients with certain types of lymphoma that have come back or don't respond to other treatments. These treatments aim to stop cancer cells from growing or kill them directly. The goal is to see if these treatments can better control or shrink the cancer compared to not using them.
Recruiting
1 award
Phase 2
More about Elizabeth Brem, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Elizabeth Brem, MD has experience with
- Rituximab
- Cyclophosphamide
- Nivolumab
- Venetoclax
- Vincristine Sulfate
- Doxorubicin Hydrochloride
Breakdown of trials Elizabeth Brem, MD has run
Lymphoma
Large B-Cell Lymphoma
Follicular Lymphoma
Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elizabeth Brem, MD specialize in?
Elizabeth Brem, MD focuses on Lymphoma and Large B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved 13q positive patients, or patients who are 13q negative.
Is Elizabeth Brem, MD currently recruiting for clinical trials?
Yes, Elizabeth Brem, MD is currently recruiting for 4 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Elizabeth Brem, MD has studied deeply?
Yes, Elizabeth Brem, MD has studied treatments such as Rituximab, Cyclophosphamide, Nivolumab.
What is the best way to schedule an appointment with Elizabeth Brem, MD?
Apply for one of the trials that Elizabeth Brem, MD is conducting.
What is the office address of Elizabeth Brem, MD?
The office of Elizabeth Brem, MD is located at: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California 92868 United States. This is the address for their practice at the UC Irvine Health/Chao Family Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.